Searched for
ONESOURCE
Promoters Buying: 9 Nifty 500 stocks that saw stake hikes in March quarterPromoters are showing increased confidence in several Nifty 500 companies. Their shareholding has risen in the March 2026 quarter compared ...24 Apr, 2026, 11.03 PM IST- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...24 Apr, 2026, 05.29 AM IST
- How Ashish Kacholia, Mukul Agrawal, Madhu Kela, Dolly Khanna reshuffled portfolios amid Iran war?Amid a sharp market sell-off triggered by Iran war tensions and rising oil prices, marquee investors like Ashish Kacholia, Mukul Agrawal, M...22 Apr, 2026, 10.43 AM IST
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic markets extended gains for a third session, led by financial and FMCG stocks, with Nifty 50 and BSE Sensex rising sharply. Lower v...21 Apr, 2026, 09.24 PM IST
- OneSource Specialty Pharma shares nosedive 18% on weak Q3. Here’s what happenedOneSource Specialty Pharma shares plunged 18% after reporting a net loss of Rs 47 crore for the December quarter, a significant reversal fr...27 Jan, 2026, 12.35 PM IST
- Strides Founder raises Rs 1000 crore to refinance debtArun Kumar, founder of Strides Group and OneSource, has secured ₹1,000 crore by pledging shares. This move refinances existing loans, exten...18 Oct, 2025, 12.23 AM IST
- Big fat legal war bursts out ahead of Novo Nordisk's Wegovy launchNovo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from selling semaglutide ...31 May, 2025, 05.30 AM IST
- JM Financial initiates coverage on OneSource Specialty Pharma with a Buy call, target price Rs 2,049JM Financial initiates a Buy call on OneSource Specialty Pharma, setting a target price of Rs 2,049, driven by its unique CDMO positioning ...05 May, 2025, 09.11 AM IST
- 360 ONE Asset acquires stake in OneSource Specialty Pharma360 ONE Asset has acquired a stake in OneSource Specialty Pharma, a Contract Development and Manufacturing Organization (CDMO), for an undi...21 Nov, 2024, 06.24 PM IST
- Strides Pharma's OneSource raises Rs 801 crore in pre-listing roundOneSource Specialty Pharma, an associate of Strides Pharma, secured Rs. 801 crore from investors including HBM Healthcare Investments and W...16 Oct, 2024, 03.19 PM IST
- OneSource in talks to raise Rs 1,670 crore in pre-listing roundOneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopha...26 Sep, 2024, 12.42 AM IST
- Strides secures shareholders' nod for OneSource specialty CDMO unitStrides Pharma Science has received approval from shareholders and secured creditors to create OneSource, a specialty pharma CDMO. The comp...11 Sep, 2024, 03.41 PM IST
- Proxy advisors vote against Strides Pharma’s consolidation schemeProxy advisory firms have recommended investors vote against Strides Pharma's proposal to consolidate businesses with Steriscience and Ones...09 Sep, 2024, 05.53 PM IST
- Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...26 Sep, 2023, 12.17 PM IST
- Strides Pharma to spin off CDMO assets to form a separate unitPharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...26 Sep, 2023, 01.06 AM IST
- Strides Pharma to spin off contract development unitStrides Pharma Science on Monday said it would spin off its contract development and manufacturing organisation (CDMO) and soft gelatin bus...25 Sep, 2023, 04.39 PM IST
- Cognizant acquires two verticals of Workday partner OneSourceCognizant will add 400 employees of OneSource through the deal, bolstering its strength of certified professionals who can do Workday imple...02 Nov, 2022, 05.59 PM IST
Load More
